TY  - GEN
AU  - Dupont,Jeanette
AU  - Jensen,Helle A
AU  - Jensen,Benny V
AU  - Pfeiffer,Per
TI  - Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer
SN  - 0284-186X
PY  - 2007///1002
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Capecitabine
KW  - Denmark
KW  - Deoxycytidine
KW  - administration & dosage
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Epirubicin
KW  - Esophagogastric Junction
KW  - pathology
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Severity of Illness Index
KW  - Stomach Neoplasms
KW  - Survival Analysis
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1080/02841860600949578
ER  -